CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K/A Event Results of operations
- 8-K Event Results of operations · Other events
- 8-K Event Executive or director change
- SC 13D/A Stake Beneficial Ownership Report
- NT 10-K Other NT 10-K
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
Page 52 of 121 · 2,419 filings